Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
55.6M
-
Shares change
-
+5.05K
-
Total reported value, excl. options
-
$3.57B
-
Value change
-
+$326K
-
Put/Call ratio
-
1.88
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$64.32
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2013
177 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2013.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.6M shares
of 132M outstanding shares and own 42.25% of the company stock.
Largest 10 shareholders include FMR LLC (9.51M shares), WELLINGTON MANAGEMENT CO LLP (8.15M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.81M shares), VANGUARD GROUP INC (2.97M shares), BlackRock Fund Advisors (2.21M shares), FRANKLIN RESOURCES INC (2.14M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1.91M shares), GILDER GAGNON HOWE & CO LLC (1.9M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (1.59M shares), and BlackRock Institutional Trust Company, N.A. (1.49M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.